Brink Therapeutics
Paris
About Brink Therapeutics
Brink Therapeutics is a Biotechnology Research firm conducting cell therapy research using reprogrammed recombinases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $4.0M
- Funding stage: Seed
- Last round: Seed (Apr 2025)
- Website: brinktx.com
Industries & Categories
Biotechnology, Product Research, Test and Measurement
Social Profiles
Canonical: https://fsome.com/organization/brink-therapeutics-123332 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.